Concordia International (CXRXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CXRXF | BVS | RLMD | ||
| Company | Concordia International | Bioventus Inc Cl A | Relmada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 17.1500 | 9.85 | 7.56 | ||
| High | 17.1800 | 10.22 | 7.80 | ||
| Low | 15.5100 | 9.81 | 7.42 | ||
| Latest | 17.0600 | 10.11 | 7.64 | ||
| Change | -0.1200 | +0.24 | +0.12 | ||
| % Change | -0.70% | +2.43% | +1.60% | ||
| Volume | 800 | 404,200 | 944,100 | ||
| 20-Day Average Volume | 1,685 | 450,655 | 1,290,875 | ||
| Previous Close | 17.1800 | 9.87 | 7.52 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.0490 | 9.75 | 7.23 | ||
| 20-Day Raw Stochastic | 77.89% | 68.45% | 77.38% | ||
| 20-Day Relative Strength | 56.76 | 58.68 | 62.26 | ||
| Weighted Alpha | +42.08 | +51.48 | +553.15 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.64% since 05/27/21 | +0.20% since 04/24/26 | +5.96% since 04/24/26 | ||
| Low | 15.5100 on 06/07/21 | 9.56 on 04/29/26 | 6.82 on 04/28/26 | ||
| High | 17.5000 on 06/01/21 | 10.30 on 04/28/26 | 7.80 on 05/01/26 | ||
| 1-Month | |||||
| %Chg | +1.55% since 05/06/21 | +10.49% since 04/01/26 | +7.61% since 04/01/26 | ||
| Low | 15.5100 on 06/07/21 | 8.70 on 04/07/26 | 6.60 on 04/02/26 | ||
| High | 17.5000 on 06/01/21 | 10.76 on 04/17/26 | 7.94 on 04/10/26 | ||
| 3-Month | |||||
| %Chg | +1.55% since 03/05/21 | +27.49% since 01/30/26 | +115.21% since 01/30/26 | ||
| Low | 15.5100 on 06/07/21 | 7.78 on 02/11/26 | 3.22 on 02/04/26 | ||
| High | 17.5000 on 06/01/21 | 10.76 on 04/17/26 | 7.94 on 04/10/26 | ||
| 6-Month | |||||
| %Chg | +259.16% since 12/07/20 | +54.35% since 10/31/25 | +238.05% since 10/31/25 | ||
| Low | 3.8900 on 12/31/20 | 6.47 on 11/21/25 | 2.15 on 11/03/25 | ||
| High | 18.0000 on 02/04/21 | 10.76 on 04/17/26 | 7.94 on 04/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 834,456 | 840,697 | 801,344 | ||
| Shares Outstanding, K | 48,913 | 83,155 | 104,888 | ||
| Annual Sales | 525,580,000 | 568,090,000 | 0 | ||
| Annual Net Income | -74,860,000 | 22,730,000 | -57,390,000 | ||
| Last Quarter Sales | 136,110,000 | 157,900,000 | 0 | ||
| Last Quarter Net Income | -15,240,000 | 14,760,000 | -19,870,000 | ||
| 60-Month Beta | N/A | 0.72 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.24 on 03/05/26 | -0.27 on 03/19/26 | ||
| Earnings Date | 08/11/21 | 05/06/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.51 | 0.00 | ||